- Home
- CNTA vs PINC Comparison
CNTA vs PINC Comparison
Compare CNTA & PINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- PINC
- Stock Information
- Founded
- CNTA 2020
- PINC 2013
- Country
- CNTA United Kingdom
- PINC United States
- Employees
- CNTA N/A
- PINC N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- PINC Other Consumer Services
- Sector
- CNTA Health Care
- PINC Consumer Discretionary
- Exchange
- CNTA Nasdaq
- PINC Nasdaq
- Market Cap
- CNTA 1.6B
- PINC 1.9B
- IPO Year
- CNTA 2021
- PINC 2013
- Fundamental
- Price
- CNTA $13.17
- PINC $21.79
- Analyst Decision
- CNTA Strong Buy
- PINC Hold
- Analyst Count
- CNTA 10
- PINC 6
- Target Price
- CNTA $28.78
- PINC $22.20
- AVG Volume (30 Days)
- CNTA 1.2M
- PINC 2.2M
- Earning Date
- CNTA 08-12-2025
- PINC 08-19-2025
- Dividend Yield
- CNTA N/A
- PINC 3.83%
- EPS Growth
- CNTA N/A
- PINC N/A
- EPS
- CNTA N/A
- PINC 0.63
- Revenue
- CNTA $15,000,000.00
- PINC $1,260,388,000.00
- Revenue This Year
- CNTA N/A
- PINC N/A
- Revenue Next Year
- CNTA N/A
- PINC N/A
- P/E Ratio
- CNTA N/A
- PINC $20.11
- Revenue Growth
- CNTA 118.88
- PINC 7.16
- 52 Week Low
- CNTA $8.46
- PINC $17.23
- 52 Week High
- CNTA $19.09
- PINC $23.56
- Technical
- Relative Strength Index (RSI)
- CNTA 53.38
- PINC 43.32
- Support Level
- CNTA $12.74
- PINC $21.43
- Resistance Level
- CNTA $14.27
- PINC $22.10
- Average True Range (ATR)
- CNTA 0.71
- PINC 0.46
- MACD
- CNTA 0.08
- PINC -0.11
- Stochastic Oscillator
- CNTA 56.11
- PINC 32.15
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.